Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1388 of 6351
-
Hidden pelvic vein issues may sabotage leg vein surgery, study warns
Knowledge-focused OngoingResearch Summary: Impact of Pelvic Congestion Syndrome on Lower Limb Varicose Vein Treatment This prospective cohort study investigates the prevalence of Pelvic Congestion Syndrome (PCS) among women undergoing lower limb varicose vein ablation and its impact on post-operative qu…
Sponsor: Chengdu University of Traditional Chinese Medicine • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New hope for gout sufferers: drug dotinurad targets high uric acid
Disease control Recruiting nowThe primary objective of this trial is to evaluate the efficacy of dotinurad in lowering serum uric acid (sUA) at Week 24 in participants with gout who are XOI intolerant or have failed uricase treatment.
Phase 2 • Sponsor: Crystalys Therapeutics • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New vaccine aims to shield stem cell patients from dangerous virus
Prevention Recruiting nowThis phase Ib trial tests the safety, side effects, and how well cytomegalovirus (CMV)-modified vaccinia Ankara (MVA) Triplex vaccine works in enhancing CMV-specific immunity and preventing CMV viremia in patients undergoing haploidentical hematopoietic stem cell transplant. Hapl…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Prevention
Last updated Jul 30, 2026 00:00 UTC
-
New drug aims to stop cancer wasting
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate the efficacy and safety of ASCA101 for the treatment of Cachexia in solid tumor patients. The main questions it aims to answer are: Can the efficacy of ASCA101 in improving cachexia be evaluated based on changes in body weight measu…
Phase 2 • Sponsor: MetaFines • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Tailoring sickle cell drug doses: a new hope for nigerian patients
Knowledge-focused Not yet recruitingThe wide interindividual variability in clinical response to hydroxyurea therapy in the management of sickle cell disease has limited its use. These variabilities have been linked to differences in pharmacodynamics, pharmacokinetics, and pharmacogenetics. This study, therefore, a…
Sponsor: Ochuko Orherhe • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Higher dose hormone therapy aims to control rare calcium disorder
Disease control Recruiting nowThis trial has a treatment duration of 78 weeks and will include adult participants already on treatment with palopegteriparatide at doses at or greater than 30 mcg/day. All participants will receive subcutaneous palopegteriparatide during the trial and will be individually and p…
Phase 3 • Sponsor: Ascendis Pharma Bone Diseases A/S • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
New at-home device aims to improve bladder control for spinal cord injury patients
Disease control Recruiting nowThe purpose of this study is to determine the safety and efficacy of Injectrode Tibial Nerve Stimulation for bladder function in people with spinal cord injury.
Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Second chance: new drug tested for stubborn thyroid eye disease
Disease control Recruiting nowThe main objective of this trial is to assess the efficacy of AMG 732 in participants with thyroid eye disease (TED) who are defined as primary nonresponders or relapsed during the safety follow-up in the parent trial (NCT06401044).
Phase 2 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Can baking soda save kidneys? new trial tests cheap treatment for ICU patients
Disease control Recruiting nowThe study investigates whether sodium bicarbonate is able to reduce the occurrence of major adverse kidney events on day 90 (MAKE90) in critically ill patients with metabolic acidosis and acute kidney injury (AKI). While its efficacy in this context has been suggested in a subgro…
Phase 4 • Sponsor: Universität Münster • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a two-drug combo beat the HTLV-1 virus?
Disease control Recruiting nowThis phase 2b, open-label, randomized controlled trial evaluates the efficacy and safety of dolutegravir (DTG) alone versus dolutegravir combined with tenofovir disoproxil fumarate (TDF) in individuals with HTLV-1 infection and associated clinical manifestations. The primary obje…
Phase 2 • Sponsor: Carlos Brites • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New pill aims to reverse liver scarring in fatty liver patients
Disease control Recruiting nowThe purpose of this study is to evaluate the safety, tolerability, and pharmacodynamic effects of AZD2389 in adult participants with steatotic liver disease (SLD) and advanced fibrosis.
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Could oxygen therapy ease cancer drug pain?
Symptom relief Recruiting nowpatienst who survived from breast cancer are prescribed long administraion of aromatase inhbitors.. these inhibitors usually induce musckloskeletal pains. Programmed phsyical activity are reommended to improve these pains but effects of HYperbaric oxygen on these pain was not inv…
Sponsor: Cairo University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Buddy system: new study tests friend talks to curb Booze-Fueled assaults
Prevention Recruiting nowThis Phase 2 trial will to examine the efficacy of a brief dyad-based motivational interview (PAIRS MI) delivered to friend dyads with an active treatment-as-usual condition, and a 1-year follow-up.
Sponsor: State University of New York at Buffalo • Aim: Prevention
Last updated Jul 15, 2026 00:00 UTC
-
New combo trial hopes to tame advanced breast cancer
Disease control Recruiting nowA study to investigate camizestrant in combination with atirmociclib in participants with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer previously treated with a cyclin dependent kinase 4/6 (CDK4/6) inhibitor.
Phase 2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New shot could ease IBS-D symptoms in major trial
Symptom relief Recruiting nowThe purpose of this study is to evaluate how well brenipatide (LY3537031) is tolerated, what side effects may occur, and the safety and efficacy in participants with Irritable Bowel Syndrome-Diarrhea (IBS-D). The study drug will be administered subcutaneously (SC) (under the skin…
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Symptom relief
Last updated Sep 10, 2026 00:00 UTC
-
Peer support may lift the cloud of loneliness for older gay men with HIV
Symptom relief Recruiting nowOlder gay and bisexual men living with HIV (OGBMLH) are more likely to experience depression and loneliness, which can lead to negative health outcomes. This mixed-methods research study will assess the feasibility and acceptability of the Bridge to Belonging (B2B) intervention. …
Sponsor: Fenway Community Health • Aim: Symptom relief
Last updated Aug 15, 2026 00:00 UTC
-
New trial: can hormone pills boost targeted cancer therapy?
Disease control Recruiting nowThe goal of this study is to determine whether the addition of Androgen Deprivation Therapy (ADT) utilizing the study drug ELIGARD® to Recurrence- Directed Therapy (RDT) improves progression-free survival (PFS) compared to RDT alone in patients with early radio-recurrent oligo-me…
Phase 2 • Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Could a 5-Session therapy help teens with PTSD?
Symptom relief OngoingWritten Exposure Therapy (WET) is a five-session mental health therapy for posttraumatic stress disorder (PTSD). Research shows that it works as well as longer treatments for PTSD among people over 18, even though it requires fewer sessions than other PTSD therapies. However, WET…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can a common drug protect organs during sepsis?
Disease control By invitation onlyIn this single-center, single-blind, randomized, placebo-controlled pilot trial. The effect of Racecadotril on the improvement of organ function will be investigated in patients with sepsis. Researchers will screen patients admitted to the Department of Critical Care Medicine at …
Phase 1/2 • Sponsor: Zhujiang Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Chatbot vs. HPV: 18,000 parents test digital nudge for teen vaccination
Prevention Not yet recruitingThis is an interventional study targeting parents of junior high school girls. The primary objective of the study is to evaluate the effectiveness of a vaccine chatbot in improving HPV vaccination rates among parents' junior high school girls. The secondary objectives are to eval…
Sponsor: Xiamen University • Aim: Prevention
Last updated Jun 27, 2026 12:08 UTC